NAMI vs NCEW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

NAMI

46.3
AI Score
VS
NAMI Wins

NCEW

40.3
AI Score

Investment Advisor Scores

NAMI

46score
Recommendation
HOLD

NCEW

40score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NAMI NCEW Winner
Revenue 59.06M 44.08M NAMI
Net Income -13.49M -10.67M NCEW
Gross Margin 11.0% 0.4% NAMI
Net Margin -22.8% -24.2% NAMI
Operating Income -14.91M -10.84M NCEW
ROE -112.5% -201.8% NAMI
ROA -49.1% -73.5% NAMI
Total Assets 27.49M 14.53M NAMI
Cash 9.19M 645,912 NAMI
Current Ratio 1.53 1.47 NAMI
Free Cash Flow -3.63M -3.47M NCEW

Relative Price Performance (Last 90 Days)

NAMI 1M: -45.4% · 3M: +524.6% NCEW 1M: -0.1% · 3M: +1.2%

Current Technical Phase

NAMI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.8 · Price: $1.83

NCEW

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.2 · Price: $16.24

Fundamentals Snapshot

Metric NAMI NCEW
Market Cap
Forward P/E 0.0 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin 0.1% 0.0%
Operating Margin -0.4% 0.0%
EPS -4.64 -3.09
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NAMI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.